Gülşah Kalay

Gülşah Kalay

Auto-generated profile, based on publicly available information

Gülşah Kalay

Department of Pediatric Allergy and Clinical Immunology Başakşehir Çam and Sakura City Hospital İstanbul Türkiye

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2023 in Güncel Pediatri
Verified
Journal Article
Closed access
GKGülşah Kalay
Gülşah Kalay
BSBetül Berrin Sevinir
Betül Berrin Sevinir
MDMetin Demirkaya
Metin Demirkaya
UAUtku Aygüneş
Utku Aygüneş
MEMehtap Ertekin
Mehtap Ertekin

1 July 2026 in Scandinavian Journal of Immunology
Verified
Journal Article
Closed access
SUSelami Ulaş
Selami Ulaş
SASerdar Al
Serdar Al
SNSezin Naiboğlu
Sezin Naiboğlu
KYKübra Yırgın
Kübra Yırgın
SKSibel Kaplan
Sibel Kaplan
ÇAÇiğdem Aydoğmuş
Çiğdem Aydoğmuş

2 January 2024 in Journal of Molecular Virology and Immunology
Verified
Journal Article
Open access
IYİlKe Yıldırım
İlKe Yıldırım
ITIşılay Turan
Işılay Turan
SUSelami Ulaş
Selami Ulaş
SNSezin Naiboğlu
Sezin Naiboğlu
GKGülşah Kalay
Gülşah Kalay
ÇAÇiğdem Aydoğmuş
Çiğdem Aydoğmuş
Hepatic veno occlusive disease with immunodeficiency syndrome (VODI) is an autosomal recessive primary immunodeficiency associated with hepatic vascular occlusion and fibrosis. The immunodeficiency is characterized by severe hypogammaglobulinemia, combined T and B cell immunodeficiency, absent lymph node germinal centers, and absence of tissue plasma cells. VODI was first described in 1976 in an Australian Lebanese population. In our patient who came to the emergency department with septic shock, all immunoglobulins were too low to count. In the blood analysis of the patient, it was observed that there was no antibody response. Lymphocyte subgroups were almost normal. According to the whole exome sequence (WES) analysis, it was observed that he had a VODI gene defect. There was an increase in intermittent liver function tests and ursodeoxycholic-acid (UDCA) was started. However, hepatic fibrosis has not yet been detected by radiological methods. During the follow-up of our patient, there was serious weight loss due to chronic (prolonged) norovirus infection. The patient is preparing for a bone marrow transplant. The VODI gene defect should be considered in the differential diagnosis in patients with sepsis, invasive infection, and hypogammaglobulinemia, especially in the early stages of life. With early detection of the disease, patients are monitored regularly with intravenous immunoglobulin (IVIG) prophylactic treatments. In this way, patients can be caught before hepatic fibrosis develops and the development of irreversible damage can be prevented, such as failure of the liver.